Xtrenbo Figure 1 (Xtrenbo Denosumab Qbde Injection 1)
This is not properly recognizable.*
Xtrenbo Injection
Product Images NDC 0143-9166
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Xtrenbo (NDC 0143-9166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Xtrenbo_label (Xtrenbo Denosumab Qbde Injection 2)
This is information about a medication in a single-dose vial with a dosage of 120 mg in 1.7 mL. It is intended for subcutaneous use only. The medication is denosumab-gbde from bikiama Pharmaceuticals USA Inc, with US license number 2356. Make sure to discard any unused portion following injection. The lot number and expiration date provided are 0100013966016 and 29492820 respectively.*
Carton (Xtrenbo Denosumab Qbde Injection 3)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
